The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.
Out of stock
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Insomnia
Recommended starting dose: 10 mg PO taken no more than once per night and within 30 minutes of going to bed.
Not to exceed 20 mg once daily.
Hepatic impairment
Mild-to-moderate: No dosage adjustment required
Severe: Not recommended
Child Dose
Safety and efficacy not established
Renal Dose
Renal impairment: No dosage adjustment required
Contraindication
Hypersensitivity. Narcolepsy
Mode of Action
Orexin receptor antagonist; orexin, also called hypocretin, is a neurotransmitter that regulates arousal, wakefulness, and appetite
Blocking the binding of wake-promoting neuropeptides orexin A and orexin B to receptors OX1R and OX2R is thought to suppress wake drive
Precaution
Can impair daytime wakefulness; CNS depressant effects can last for up to several days after discontinuation Can impair driving skills and may increase the risk of falling asleep while driving Dosage adjustments of suvorexant and concomitant CNS depressants may be necessary when administered together because of potentially additive effects Use with other drugs to treat insomnia is not recommended Risk of next-day impairment, including impaired driving, is increased if taken with less than a full night of sleep remaining, if a higher than the recommended dose is taken, if coadministered with other CNS depressants, or if coadministered with other drugs...
